Oral microbiome components predict response to neoadjuvant chemotherapy in triple-negative breast cancer patients

The oral microbiome has emerged as a critical biomarker and regulator in cancer development and treatment response, garnering increasing attention from researchers. However, its specific role in breast cancer, particularly in triple-negative breast cancer (TNBC), remains poorly understood. The influ...

Descripció completa

Dades bibliogràfiques

Autors principals:	Xiaoyan Fu, Ze Huang, Zongyan Li, Zuxiao Chen, Zhijie Wu, Qingyu Yang, Haiyan Li
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2025-07-01
Col·lecció:	Frontiers in Oncology
Matèries:	oral microbiome triple-negative breast cancer neoadjuvant chemotherapy sensitivity response-prediction model biomarker
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1546044/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!